Please login to the form below

Not currently logged in
Email:
Password:

PRIME designation

This page shows the latest PRIME designation news and features for those working in and with pharma, biotech and healthcare.

GSK files anti-BCMA drug for myeloma after second trial win

GSK files anti-BCMA drug for myeloma after second trial win

The ADC has been given a breakthrough designation by the FDA as well as PRIME designation from the EMA in Europe.

Latest news

More from news
Approximately 2 fully matching, plus 10 partially matching documents found.

Latest Intelligence

  • Cortellis Drugs to Watch in 2020 report Cortellis Drugs to Watch in 2020 report

    The 11 drugs identified collectively hold 18 orphan drug designations, four FDA breakthrough therapy designations, two EU PRIME designations and one Japanese SAKIGAKE designation.

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    Bluebird says its decision to file in Europe first was in part thanks to LentiGlobin being accepted on to the EMA’s PRIME fast track designation, which allows early discussions about ... Upadacitinib is already in a phase 3 trial in atopic dermatitis

  • The European Medicines Agency: PRIME’d for access? The European Medicines Agency: PRIME’d for access?

    Going for scientific advice once given the PRIME designation can also mean faster advice: a 40-day timeframe versus the 70-day standard. ... SMEs can also get a filing fee reduction. PRIME numbers after 2 years.

  • Bluebird Bio: on the cusp of a gene therapy revolution Bluebird Bio: on the cusp of a gene therapy revolution

    There is no question that these products are truly groundbreaking: three have FDA Breakthrough Therapy Designation and two have the similar PRIME designation from the EMA. ... European regulator giving the therapy its PRIME designation in September 2016.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
11 London

11 London is a strategic and creative agency working in the fields of health and humanity – complex areas, but...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics